Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese

ClinicalTrials.gov ID: NCT06445075

Public ClinicalTrials.gov record NCT06445075. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Apitegromab in Overweight and Obese Adult Subjects

Study identification

NCT ID
NCT06445075
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Scholar Rock, Inc.
Industry
Enrollment
102 participants

Conditions and interventions

Interventions

  • Apitegromab Drug
  • Placebo Drug
  • Tirzepatide Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 20, 2024
Primary completion
Mar 3, 2025
Completion
Jun 16, 2025
Last update posted
Jan 22, 2026

2024 – 2025

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
ProSciento CRU Chula Vista California 91911
AdventHealth Translational Research Institute Orlando Florida 32804
Great Lakes Clinical Trials, LLC d/b/a Flourish Research Chicago Illinois 60640
Tandem Clinical Research GI, LLC Marrero Louisiana 70072
Alliance for Multispecialty Research, LLC Norman Oklahoma 73069
Apex Mobile Clinical Research Bellaire Texas 77401
Clinical Trials of Texas, LLC dba Flourish Research San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06445075, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 22, 2026 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06445075 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →